In vivo isoproterenol treatment leads to downregulation of the mRNA encoding the cAMP response element binding protein in the rat heart

Biochem Biophys Res Commun. 1995 Oct 24;215(3):1043-9. doi: 10.1006/bbrc.1995.2569.

Abstract

The expression of different myocardial regulatory proteins is altered in human heart failure, e.g., beta 1-adrenoceptors, G-proteins and others. Similar changes in rats after 4 days treatment with isoproterenol led to the hypothesis of the cAMP pathway involved in these changes. In different cell types cAMP-dependent transcriptional activation is mediated by the cAMP-response element binding protein (CREB) which was recently shown to be expressed and phosphorylated in the human heart. Here, by the reverse transcriptase-polymerase chain reaction two alternatively spliced isoforms of CREB mRNA were found to be expressed in rat ventricles. Both isoforms were down-regulated in the ventricles of rats treated in vivo with isoproterenol (2.4 mg/kg per day) for 4 days proposing a possible mechanism involved in expressional changes mentioned above.

Publication types

  • Comparative Study

MeSH terms

  • Adrenergic beta-Agonists / administration & dosage
  • Adrenergic beta-Agonists / pharmacology*
  • Alternative Splicing
  • Animals
  • Base Sequence
  • Blotting, Southern
  • Body Weight / drug effects
  • Cyclic AMP Response Element-Binding Protein / biosynthesis*
  • DNA Primers
  • Gene Expression Regulation / drug effects*
  • Heart / drug effects*
  • Heart Ventricles
  • Humans
  • Infusions, Parenteral
  • Isoproterenol / administration & dosage
  • Isoproterenol / pharmacology*
  • Kinetics
  • Male
  • Molecular Sequence Data
  • Myocardium / metabolism*
  • Organ Size / drug effects
  • Phosphorylation
  • Polymerase Chain Reaction
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Wistar
  • Reference Values
  • Time Factors

Substances

  • Adrenergic beta-Agonists
  • Cyclic AMP Response Element-Binding Protein
  • DNA Primers
  • RNA, Messenger
  • Isoproterenol